Zoetis Quarterly Balance Sheet
NYSE: ZTSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:03 PM ET · Delayed 15 min
Zoetis financial position
As of Jun 30, 2026, Zoetis reported total assets of $15.08 billion, up 4.1% from a year earlier against total liabilities of $11.93 billion. Shareholders' equity stood at $3.15 billion, or 20.9% of assets. The company held $1.48 billion in cash and equivalents against $9.05 billion of debt, a net debt position of $7.57 billion.
The current ratio (current assets divided by current liabilities) was 3.08, meaning short-term assets cover obligations due within a year. Debt-to-equity was 2.87.
Summary generated from market data by MetaCap's automated system. Methodology
Zoetis balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.48B | 1.94B | 2.45B | 2.08B | 1.44B | 1.72B | 1.99B | 1.71B | 1.57B | 1.98B | 2.04B | 1.75B |
| Short-Term Investments | 200.00M | — | 0 | — | — | — | — | — | — | — | — | — |
| Receivables | 1.57B | 1.51B | 1.41B | 1.54B | 1.54B | 1.36B | 1.32B | 1.41B | 1.38B | 1.29B | 1.30B | 1.26B |
| Inventory | 2.57B | 2.55B | 2.46B | 2.46B | 2.44B | 2.37B | 2.31B | 2.42B | 2.45B | 2.65B | 2.56B | 2.74B |
| Total Current Assets | 6.36B | 6.47B | 6.77B | 6.58B | 5.92B | 5.88B | 5.99B | 6.28B | 6.20B | 6.36B | 6.34B | 6.22B |
| Property, Plant & Equipment | 3.76B | 3.72B | 3.69B | 3.60B | 3.54B | 3.44B | 3.39B | 3.30B | 3.20B | 3.25B | 3.20B | 3.09B |
| Goodwill | 2.77B | 2.78B | 2.77B | 2.76B | 2.76B | 2.72B | 2.72B | 2.74B | 2.74B | 2.76B | 2.76B | 2.76B |
| Intangible Assets | 918.00M | 959.00M | 998.00M | 1.04B | 1.07B | 1.08B | 1.13B | 1.19B | 1.23B | 1.29B | 1.34B | 1.40B |
| Total Assets | 15.08B | 15.15B | 15.49B | 15.16B | 14.48B | 14.10B | 14.24B | 14.36B | 14.16B | 14.35B | 14.29B | 14.11B |
| Accounts Payable | 452.00M | 507.00M | 445.00M | 410.00M | 508.00M | 420.00M | 433.00M | 404.00M | 420.00M | 405.00M | 411.00M | 388.00M |
| Short-Term Debt | 0 | 0 | 0 | 0 | 1.35B | 1.35B | 1.35B | 0 | 0 | 24.00M | 3.00M | 2.00M |
| Total Current Liabilities | 2.06B | 2.05B | 2.17B | 1.81B | 3.37B | 3.38B | 3.41B | 1.70B | 1.80B | 1.91B | 1.89B | 1.61B |
| Long-Term Debt | 9.05B | 9.04B | 9.04B | 7.07B | 5.23B | 5.23B | 5.22B | 6.57B | 6.56B | 6.56B | 6.56B | 6.55B |
| Total Liabilities | 11.93B | 11.92B | 12.07B | 9.76B | 9.50B | 9.44B | 9.47B | 9.12B | 9.21B | 9.30B | 9.29B | 9.03B |
| Shareholders' Equity | 3.15B | 3.23B | 3.42B | 5.40B | 4.98B | 4.66B | 4.77B | 5.23B | 4.97B | 5.06B | 5.00B | 5.08B |
| Retained Earnings | 14.65B | 14.18B | 13.80B | 13.59B | 12.87B | 12.38B | 11.97B | 11.81B | 11.12B | 10.70B | 10.29B | 10.14B |
| Total Debt | 9.05B | 9.04B | 9.04B | 7.07B | 6.58B | 6.58B | 6.57B | 6.57B | 6.56B | 6.59B | 6.57B | 6.55B |
| Net Cash (Debt) | -7.37B | -7.10B | -6.59B | -4.99B | -5.15B | -4.86B | -4.58B | -4.86B | -4.99B | -4.61B | -4.53B | -4.80B |
| Shares Outstanding | 414.15M | 420.35M | 424.93M | 441.46M | 443.95M | 446.04M | 448.47M | 451.55M | 453.81M | 456.95M | 458.37M | 459.52M |
This table shows 12 quarterly periods of Zoetis's balance sheet, from Q2 2026 back to Q3 2023, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow ZTS's reporting calendar. What is a balance sheet?